Sign in
4

Changes in Ownership

C4 Therapeutics, Inc. Filed Acc 0001470831-26-000177

President & CEO gave up 48,211 shares (to pay taxes)

  • President & CEO acquired 700,000 shares (grant or award)
  • President & CEO acquired 102,125 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Hirsch Andrew President & CEO 2026-02-13 Grant or award +700,000 1,123,145 D: show line 1 in the form
Hirsch Andrew President & CEO 2026-02-14 Option exercise +81,725 1,123,145 D: show line 2 in the form
Hirsch Andrew President & CEO 2026-02-14 Shares withheld for taxes −39,154 $1.89 $74,001 1,083,991 D: show line 3 in the form
Hirsch Andrew President & CEO 2026-02-15 Option exercise +20,400 1,083,991 D: show line 4 in the form
Hirsch Andrew President & CEO 2026-02-15 Shares withheld for taxes −9,057 $1.89 $17,118 1,074,934 D: show line 5 in the form
Loading xslF345X05/wk-form4_1771452294.xml…